{"id":23068,"date":"2022-08-25T22:50:46","date_gmt":"2022-08-25T20:50:46","guid":{"rendered":"https:\/\/kapitalpartner.dk\/?p=23068"},"modified":"2022-08-25T22:50:48","modified_gmt":"2022-08-25T20:50:48","slug":"lifecare-faces-a-decisive-month","status":"publish","type":"post","link":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/","title":{"rendered":"Lifecare faces a decisive month"},"content":{"rendered":"\n<p><strong>Lifecare has today published its half-year results. It supports the investment case for an early capital injection and a significant share price trigger as early as next month.<\/strong><\/p>\n\n\n\n<p><em>Lifecare: Ticker: LIFE | Kurs: NOK 4,18 | Market Cap.: NOK 392 mio. | YTD kursudvikling: 144%<\/em><\/p>\n\n\n\n<p>Lifecare is developing a revolutionary biosensor (Sencell), inserted in the wrist, that can measure the user&#8217;s glucose level. The biosensor is the size of a grain of rice, and therefore differs significantly from existing continuous glucose monitoring (CGM) meters. This is needed by a proportion of the more than 500 million patients with diabetes, but currently the most commonly used method is multiple daily blood sampling.<\/p>\n\n\n\n<p><strong>Possible proof of concept for Sencell in humans in September<\/strong><\/p>\n\n\n\n<p>Lifecare is in its first clinical study for Sencell (LFS-SEN-001 with threaded connection). 15 people are participating in the study including 10 healthy participants and 5 patients with type 1 diabetes. The study is expected to be completed in September, and if the study is successful, additional clinical studies will be initiated (LFS-SEN-002 &amp; LFS-SEN-003 CE with wireless connection) with approximately 200 participants. It is paramount for the investment case that Lifecare manages to deliver positive data and the outcome of LFS-SEN-001 is therefore a significant price trigger for the share price.<\/p>\n\n\n\n<p><strong>Potential market launch as early as 2024<\/strong><\/p>\n\n\n\n<p>Clinical trials are fraught with risk, and it is not certain that Sencell will make it through the needle&#8217;s eye to market. However, if all goes well, the plan is to have Sencell on the market as early as 2024, so there is a short way from the first clinical trials to the product being on the market.<\/p>\n\n\n\n<p><strong>Overview of the Sencell development plan<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1188\" height=\"385\" src=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Lifecare-1.png\" alt=\"\" class=\"wp-image-23054\" srcset=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Lifecare-1.png 1188w, https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Lifecare-1-300x97.png 300w, https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Lifecare-1-768x249.png 768w\" sizes=\"(max-width: 1188px) 100vw, 1188px\" \/><\/figure>\n\n\n\n<p><strong>Capital injection in the near future<\/strong><\/p>\n\n\n\n<p>At the end of the first 6 months of the year, Lifecare had cash on hand of approximately MNOK 11.3. At the same time, the company had a cash burn of approximately MNOK 7.3 in the first 6 months of the year, which is why the company needs to raise capital this year. This is likely to be based on any positive results for the LFS-SEN-001 study, which will be completed in September.<\/p>\n\n\n\n<p class=\"has-vivid-red-color has-text-color\"><strong><a href=\"https:\/\/kapitalpartner.dk\/se-vores-interview-med-lifecare-ceo-joacim-holter-og-bliv-klogere-paa-selskabets-banebrydende-produkt\/\">Watch the interview with Lifecare&#8217;s CEO Joacim Holter on why you should invest in Lifecare<\/a><\/strong><\/p>\n\n\n\n<p><strong>Share price development year to date for Lifecare relative to Kapital Partner Nordic Healthcare Index<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"1178\" height=\"651\" src=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/image-54.png\" alt=\"\" class=\"wp-image-23021\" srcset=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/image-54.png 1178w, https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/image-54-300x166.png 300w, https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/image-54-768x424.png 768w\" sizes=\"(max-width: 1178px) 100vw, 1178px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Lifecare has today published its half-year results. It supports the investment case for an early capital injection and a significant share price trigger as early as next month. Lifecare: Ticker: LIFE | Kurs: NOK 4,18 | Market Cap.: NOK 392 mio. | YTD kursudvikling: 144% Lifecare is developing a revolutionary biosensor (Sencell), inserted in the [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":22293,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[151,165],"tags":[],"class_list":["post-23068","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-cases","category-investment-cases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Lifecare faces a decisive month | Kapital Partner A\/S<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lifecare faces a decisive month | Kapital Partner A\/S\" \/>\n<meta property=\"og:description\" content=\"Lifecare has today published its half-year results. It supports the investment case for an early capital injection and a significant share price trigger as early as next month. Lifecare: Ticker: LIFE | Kurs: NOK 4,18 | Market Cap.: NOK 392 mio. | YTD kursudvikling: 144% Lifecare is developing a revolutionary biosensor (Sencell), inserted in the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/\" \/>\n<meta property=\"og:site_name\" content=\"Kapital Partner A\/S\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/kapitalpartner\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-25T20:50:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-25T20:50:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/LIFECARE-A.s-bergen2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"1064\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Anders S\u00f8ndergaard\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KapitalPartner\" \/>\n<meta name=\"twitter:site\" content=\"@KapitalPartner\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders S\u00f8ndergaard\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/\"},\"author\":{\"name\":\"Anders S\u00f8ndergaard\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed\"},\"headline\":\"Lifecare faces a decisive month\",\"datePublished\":\"2022-08-25T20:50:46+00:00\",\"dateModified\":\"2022-08-25T20:50:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/\"},\"wordCount\":383,\"publisher\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#organization\"},\"image\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/LIFECARE-A.s-bergen2.jpg\",\"articleSection\":[\"Company cases\",\"Investment cases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/\",\"url\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/\",\"name\":\"Lifecare faces a decisive month | Kapital Partner A\/S\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/LIFECARE-A.s-bergen2.jpg\",\"datePublished\":\"2022-08-25T20:50:46+00:00\",\"dateModified\":\"2022-08-25T20:50:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#primaryimage\",\"url\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/LIFECARE-A.s-bergen2.jpg\",\"contentUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/LIFECARE-A.s-bergen2.jpg\",\"width\":1500,\"height\":1064},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kapitalpartner.dk\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investment cases\",\"item\":\"https:\/\/kapitalpartner.dk\/en\/category\/investment-cases\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Lifecare faces a decisive month\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kapitalpartner.dk\/#website\",\"url\":\"https:\/\/kapitalpartner.dk\/\",\"name\":\"Kapital Partner A\/S\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kapitalpartner.dk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/kapitalpartner.dk\/#organization\",\"name\":\"Kapital Partner A\/S\",\"url\":\"https:\/\/kapitalpartner.dk\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png\",\"contentUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png\",\"width\":496,\"height\":432,\"caption\":\"Kapital Partner A\/S\"},\"image\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/kapitalpartner\",\"https:\/\/x.com\/KapitalPartner\",\"https:\/\/www.linkedin.com\/company\/10438322\",\"https:\/\/www.youtube.com\/channel\/UCODuY5PE_fxmp2nSSsq3l3w\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed\",\"name\":\"Anders S\u00f8ndergaard\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g\",\"caption\":\"Anders S\u00f8ndergaard\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lifecare faces a decisive month | Kapital Partner A\/S","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/","og_locale":"en_US","og_type":"article","og_title":"Lifecare faces a decisive month | Kapital Partner A\/S","og_description":"Lifecare has today published its half-year results. It supports the investment case for an early capital injection and a significant share price trigger as early as next month. Lifecare: Ticker: LIFE | Kurs: NOK 4,18 | Market Cap.: NOK 392 mio. | YTD kursudvikling: 144% Lifecare is developing a revolutionary biosensor (Sencell), inserted in the [&hellip;]","og_url":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/","og_site_name":"Kapital Partner A\/S","article_publisher":"https:\/\/www.facebook.com\/kapitalpartner","article_published_time":"2022-08-25T20:50:46+00:00","article_modified_time":"2022-08-25T20:50:48+00:00","og_image":[{"width":1500,"height":1064,"url":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/LIFECARE-A.s-bergen2.jpg","type":"image\/jpeg"}],"author":"Anders S\u00f8ndergaard","twitter_card":"summary_large_image","twitter_creator":"@KapitalPartner","twitter_site":"@KapitalPartner","twitter_misc":{"Written by":"Anders S\u00f8ndergaard","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#article","isPartOf":{"@id":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/"},"author":{"name":"Anders S\u00f8ndergaard","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed"},"headline":"Lifecare faces a decisive month","datePublished":"2022-08-25T20:50:46+00:00","dateModified":"2022-08-25T20:50:48+00:00","mainEntityOfPage":{"@id":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/"},"wordCount":383,"publisher":{"@id":"https:\/\/kapitalpartner.dk\/#organization"},"image":{"@id":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#primaryimage"},"thumbnailUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/LIFECARE-A.s-bergen2.jpg","articleSection":["Company cases","Investment cases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/","url":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/","name":"Lifecare faces a decisive month | Kapital Partner A\/S","isPartOf":{"@id":"https:\/\/kapitalpartner.dk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#primaryimage"},"image":{"@id":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#primaryimage"},"thumbnailUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/LIFECARE-A.s-bergen2.jpg","datePublished":"2022-08-25T20:50:46+00:00","dateModified":"2022-08-25T20:50:48+00:00","breadcrumb":{"@id":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#primaryimage","url":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/LIFECARE-A.s-bergen2.jpg","contentUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/LIFECARE-A.s-bergen2.jpg","width":1500,"height":1064},{"@type":"BreadcrumbList","@id":"https:\/\/kapitalpartner.dk\/en\/lifecare-faces-a-decisive-month\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kapitalpartner.dk\/en\/"},{"@type":"ListItem","position":2,"name":"Investment cases","item":"https:\/\/kapitalpartner.dk\/en\/category\/investment-cases\/"},{"@type":"ListItem","position":3,"name":"Lifecare faces a decisive month"}]},{"@type":"WebSite","@id":"https:\/\/kapitalpartner.dk\/#website","url":"https:\/\/kapitalpartner.dk\/","name":"Kapital Partner A\/S","description":"","publisher":{"@id":"https:\/\/kapitalpartner.dk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kapitalpartner.dk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kapitalpartner.dk\/#organization","name":"Kapital Partner A\/S","url":"https:\/\/kapitalpartner.dk\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/","url":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png","contentUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png","width":496,"height":432,"caption":"Kapital Partner A\/S"},"image":{"@id":"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/kapitalpartner","https:\/\/x.com\/KapitalPartner","https:\/\/www.linkedin.com\/company\/10438322","https:\/\/www.youtube.com\/channel\/UCODuY5PE_fxmp2nSSsq3l3w"]},{"@type":"Person","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed","name":"Anders S\u00f8ndergaard","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g","caption":"Anders S\u00f8ndergaard"}}]}},"_links":{"self":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts\/23068"}],"collection":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/comments?post=23068"}],"version-history":[{"count":1,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts\/23068\/revisions"}],"predecessor-version":[{"id":23074,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts\/23068\/revisions\/23074"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/media\/22293"}],"wp:attachment":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/media?parent=23068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/categories?post=23068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/tags?post=23068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}